The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing
NCT00609895
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
INSULIN GLARGINE
Sponsor
Sanofi